Quotient Wealth Partners LLC Acquires 192 Shares of HCA Healthcare, Inc. $HCA

Quotient Wealth Partners LLC raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 22.2% during the second quarter, Holdings Channel.com reports. The fund owned 1,057 shares of the company’s stock after buying an additional 192 shares during the period. Quotient Wealth Partners LLC’s holdings in HCA Healthcare were worth $405,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of HCA Healthcare by 11.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after buying an additional 2,698 shares during the period. Park Place Capital Corp boosted its position in shares of HCA Healthcare by 2,336.0% during the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after buying an additional 1,168 shares during the period. Harrell Investment Partners LLC boosted its position in shares of HCA Healthcare by 176.3% during the second quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after buying an additional 1,158 shares during the period. Brown Advisory Inc. boosted its holdings in shares of HCA Healthcare by 53.9% in the first quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock valued at $1,600,000 after purchasing an additional 1,622 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in shares of HCA Healthcare by 17.6% in the first quarter. GAMMA Investing LLC now owns 4,931 shares of the company’s stock valued at $1,704,000 after purchasing an additional 737 shares during the period. 62.73% of the stock is owned by institutional investors.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of brokerages recently issued reports on HCA. UBS Group boosted their price target on HCA Healthcare from $438.00 to $495.00 and gave the company a “buy” rating in a report on Tuesday. The Goldman Sachs Group assumed coverage on shares of HCA Healthcare in a research note on Tuesday. They issued a “buy” rating and a $470.00 price objective for the company. Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research note on Monday, July 28th. Weiss Ratings reiterated a “buy (b-)” rating on shares of HCA Healthcare in a report on Wednesday, October 8th. Finally, Wells Fargo & Company increased their price objective on HCA Healthcare from $375.00 to $412.00 and gave the company an “equal weight” rating in a report on Tuesday, October 7th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $434.00.

HCA Healthcare Stock Up 1.4%

HCA stock opened at $425.50 on Friday. The firm has a market cap of $99.56 billion, a P/E ratio of 17.89, a PEG ratio of 1.35 and a beta of 1.40. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $439.01. The company’s 50-day simple moving average is $410.05 and its 200-day simple moving average is $378.42.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts’ consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. HCA Healthcare’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period last year, the company posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were given a dividend of $0.72 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.